Hugo Barrera
South Florida High Intensity Drug Trafficking Area (HIDTA)
On March 13, 2016, Hugo Barrera reported as the new South Florida HIDTA Director, replacing retired former Director Timothy Wagner. Hugo J. Barrera, retired Special Agent in Charge (SAC) of the Miami Field Division, returned to his hometown of Miami in July 2008, where he oversaw and directed ATF operations until October 2015 in South Florida, Puerto Rico, and the U.S. Virgin Islands.
A native of Cuba, Mr. Barrera received his Bachelor’s Degree from Barry Catholic University, in Miami Shores, Florida. As a veteran law enforcement professional, he became an ATF Special Agent in 1983 after almost 7 years as a City of Miami Police Officer where he served as a Homicide Detective. In 1990, SAC Barrera entered ATF’s management ranks and served in the following positions: From 1990 through 1996, Resident Agent in Charge, Los Angeles Field Division, Houston Field Division (El Paso, Texas) and Boston Field Division (Maine and New Hampshire). From 1996 to 1998 Special Agent Barrera was appointed to the Office of Professional Responsibility and Security Operations (Internal Affairs) at ATF Headquarters in Washington, DC.

In April of 2000, Special Agent Barrera was appointed as the SAC of the Miami Field Division. He oversaw ATF’s investigative efforts in South Florida with focus on the post 9-11 terrorist attacks.
SAC Barrera was appointed to the position of Deputy Assistant Director, ATF’s Field Operations (East), in April of 2004 overseeing eight of ATF’s most populated Field Divisions in the U.S.,
He served as Deputy Assistant Director, Office of Strategic Intelligence and Information (OSII), from December 2005 until July 2008. He oversaw ATF’s collection, analysis, and utilization of information in the Bureau’s key case investigative database systems at the U.S. Bomb Data Center and International Bomb Data Center, which enhance law enforcement information sharing domestically and internationally.
A member of the Senior Executive Service, SAC Barrera served as a member of the Executive Committees of the South Florida Regional Domestic Security Task Force and of the Anti-Terrorism Task Force. He serves as a member of the Miami Dade County Chief’s Association as well as the Broward County Chief’s Association. He serves on the Firearms Committee of the International Association of Chiefs of Police, and is a member of the International Association of Bomb Technicians.
Lunch and Panel Session - High Intensity Drug Trafficking Areas (HIDTA) Program Update

Timothy Cruz
District Attorney
Plymouth County District Attorney's Office
Timothy J. Cruz has served as the Plymouth County District Attorney since November, 2001. During his tenure he has aggressively prosecuted crime in Plymouth County. Most recently, Cruz has focused his office’s efforts on battling the opioid crisis at all levels. His office also works collaboratively with local law enforcement, social service agencies, healthcare professionals, the faith community and educators on crime prevention initiatives throughout the county. Cruz has served as a member of the Massachusetts Office for Victim Assistance; Department of Corrections Advisory Council; Governor’s Council on Capital Punishment; and the Forensic Technology Subcommittee of the Governor’s Commission on Criminal Justice Innovation. He has also served two terms as the President of the Massachusetts District Attorneys Association. Previously, he worked in private practice, and as an Assistant District Attorney in Plymouth County. He is a graduate of Boston College and Suffolk University Law School and is admitted to both the Massachusetts and the United States District Court bars, as well as the United States Court of Appeals and the Supreme Court of the United States.
PC04 - Helping Traumatized and Drug Endangered Children Succeed (1.5 CE)

John Dyben, DHSc, MCAP, CMHP, ICAD
Chief Clinical Officer
Origins Behavioral Healthcare
John Dyben serves as the chief clinical officer for Origins Behavioral Healthcare, providing academic and clinical supervisory support. His background includes degrees in psychology and health science, with his doctoral practicum having focused on the dynamics, epidemiology and treatment of substance use and addiction in older adults. Dyben is an ordained pastor, clinically trained chaplain and board certified as a master addictions professional and a mental health professional in the State of Florida as well as an internationally certified alcohol and drug counselor, substance abuse professional and certified MBTI practitioner. Dyben’s responsibilities at Hanley Center at Origins have included clinical director, director of older adult and boomer recovery, director of spirituality and director of men’s recovery. He also has experience in community-based mental health and wellness fields, which included therapeutic and administrative positions with Boys Town USA. He has been an adjunct faculty member at Palm Beach State College and a faculty member of the Addiction Professionals Training Institute in West Palm Beach, Florida.
ETH1 - ETHICS WORKSHOP: Foundational Ethics and Domestic Violence: Key Issues for Clinical Professionals (An extra fee is required for this workshop - 3 Ethics CE; DV CE)
W07 - Running on Fumes: The Rising Challenge of Psychostimulant Use Disorder in Young Adults (1.5 CE)

John Eadie, MPA
Coordinator, Public Health and Prescription Drug Monitoring Program Project
National Emerging Threat Initiative, A National HIDTA Initiative
John Eadie is the Public Health & Prescription Drug Monitoring Program project coordinator for the National Emerging Threat Initiative of the National HIDTA Assistance Center. He previously served as director of the Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis University (2010-2015). For 44 years, Eadie has served in management, executive and consulting capacities in the field of public health. As director of the Division of Public Health Protection in the New York State Department of Health (1985-1995), he directed the state’s pharmaceutical diversion program, including the PDMP. He co-founded both the Alliance of States with Prescription Monitoring Programs and the National Association of State Controlled Substances Authorities, served as president for both organizations and held other posts. Since leaving New York state service in 2001, Eadie has served as a consultant on PDMPs, including serving as the administrative reviewer for the Massachusetts PDMP.
PC01 - Quantifying the Emerging Stimulant Threat For All Stakeholders

David Fawcett, PhD, LCSW PhD, LCSW
Private Practice
David Fawcett, PhD, LCSW, is a social worker and sex therapist in Fort Lauderdale specializing in gay men’s health. He is the author of "Lust, Men, and Meth: A Gay Man’s Guide to Sex and Recovery," which explores the intersection of gay men, drug use and high-risk sexual behavior. He has consulted for a variety of diverse projects, including a documentary on chemsex, specialized training curricula and the development of treatment protocols for stimulant misuse among MSM for the European Union. He frequently presents workshops on LGBT health, addiction, HIV and co-occurring disorders both in the United States and internationally, and has served on the Project Coordinating Committee for SAMHSA’s HIV and Mental Health Training and Resource Center. Fawcett has been featured on SAMHSA’s “Road to Recovery” television series. In addition, he frequently provides workshops on aging and mental health issues among long-term survivors of HIV/AIDS and is a trainer for The Reunion Project. He is a regular contributor to a number of journals and websites, writing about HIV, mental health and substance use.
P04 - Untangling Meth, Sex and Intimacy (1.5 CE)

Mark Gold, MD
Cocaine and Addiction Researcher
Mark S. Gold, MD, is a teacher, translational researcher, author, mentor and inventor best known for his work on the brain systems underlying the effects of opiate drugs, cocaine and food. He has worked as an advisor to several White House drug czars, National Institute on Drug Abuse directors and National Institute of Mental Health directors over his more than 40-year career. Gold was co-inventor of the use of clonidine in opioid withdrawal and the dopamine hypothesis for cocaine addiction and anhedonic withdrawal. He pioneered the use of clonidine and lofexidine in the late 1970s and early 1980s. Gold has earned a number of national awards for his research, including the Foundations Fund Prize, the McGovern Award for Lifetime Achievement, the National Leadership Award from the National Association of Addiction Treatment Providers, the DARE Lifetime Achievement Award and the PATH Foundation’s Lifetime Achievement Award--presented to him by drug czar Michael Botticelli. He was awarded distinguished alumni awards from Yale University and Washington University.
P01- Welcome and Opening - The Cocaine and Methamphetamine Crisis 2018: Evidence from DEA and CDC (1 CE)

Jim Hall, PhD
Senior Epidemiologist
Center for Applied Research on Substance Use and Health Disparities Nova Southeastern University
James N. Hall is a drug abuse epidemiologist affiliated with Nova Southeastern University’s Center for Applied Research on Substance Abuse and Health Disparities. He is the Miami-based member of the National Institute on Drug Abuse’s Community Epidemiology Work Group. Hall compiles local drug use data including hospitalizations, deaths, addiction treatment and prevalence, as well as drug pricing, strength and abuse trends. He works closely with local drug use coalitions, law enforcement and other community organizations. Hall served as the executive director of Up Front Drug Information and Education Center in Miami from 1982-2012 and was the recipient of the 2010 Path of Public Health Award for Epidemiology and Disease Surveillance Services from Florida International University.
P02 - Cycles of Speed: The Changing Patterns of Stimulant Epidemics (1 CE)

Norman Hoffmann, PhD
Evince Clinical Assessments
Norman G. Hoffmann, PhD, president of Evince Clinical Assessments, is an internationally recognized expert in the development of scientifically sound assessment instruments and the evaluation of behavioral health treatment programs. The instruments include brief and comprehensive interviews for the identification of mental health and substance use disorders in accordance with current diagnostic criteria as well as treatment planning aids based on the American Society of Addiction Medicine Criteria. Hoffmann has provided consultation services on assessment and evaluation issues for state and federal agencies, corporations and public organizations in the U.S., Canada, Sweden and Norway. Hoffmann led the team that developed the first placement criteria for multiple levels of care and was the lead author on the first American Society of Addiction Medicine patient placement criteria. His work on treatment evaluation provided evidence for the societal and financial benefits from addictions treatment and a foundation for empirically supported funding of treatment services. Additionally, Hoffmann served on first joint accreditation panel for prisons, probation, and parole in the United Kingdom. His publications include more than 200 articles, book chapters, and other publications. Hoffmann received his doctorate in clinical psychology from the University of Minnesota. Although employed largely in the private sector, his faculty appointments include the University of Texas Medical Branch, University of Minnesota, and Brown University. He is currently adjunct professor of psychology at Western Carolina University
P03 -The Meth Epidemic: Impact on Correctional Populations and What to Do about It (1.5 CE)

Dana Hunt, PhD
Principal Scientist
Abt Associates
Dana Eser Hunt, PhD, is a widely recognized expert with over 35 years of experience in research in alcohol and drug use and methodological issues in the field. She has managed several large multi-site research projects for the National Institute on Drug Abuse, the Office of National Drug Control Policy (ONDCP) and the National Institute of Justice, including a 35 site Arrestee Drug Abuse Monitoring program. Hunt also currently serves as senior staff on ONDCP’s High Intensity Drug Trafficking Area (HIDTA) performance audit project, examining each of the HIDTA task force’s performance in stemming high level drug trafficking.
P03 -The Meth Epidemic: Impact on Correctional Populations and What to Do about It (1.5 CE)

Edward Jacoubs, MSW
Director of Grants and Sponsored Projects
Plymouth County District Attorney's Office
Edward Jacoubs is director of grants and special projects for the Plymouth County District Attorney’s Office. He brings to the board experience designing and implementing programs for off-track youth, and he has authored and received numerous grants focused on supporting Map Academy’s target population. Jacoubs will help facilitate change for high-risk youth through his deep connections to local organizations that can provide resources and supports to Map Academy students and families. Additionally, he is the chair of the Map Academy Board of Trustees.
PC04 - Helping Traumatized and Drug Endangered Children Succeed (1.5 CE)

Hotse Langeraar
Meridian Treatment Solutions
W01 - Panel Session - Breaking Through the Walls of Dishonesty (1.5 CE)

Lindsay LaSalle, Senior Staff Attorney
Senior Staff Attorney
Drug Policy Alliance
Lindsay LaSalle is a Senior Staff Attorney with the Drug Policy Alliance’s Office of Legal Affairs and an expert and strategist in the areas of harm reduction and treatment as it relates to drug policy. In her role as an attorney, LaSalle has advocated for a public health approach to problematic drug use that is grounded in science and compassion and for alternative solutions to supply-side tactics and incarceration.

She drafts harm reduction, treatment, and health-related legislation across the country, including bills that provide legal protections for people who seek medical assistance in the event of an overdose, improve access to the overdose antidote naloxone, permit syringe exchange programs, remove barriers to treatment medications such as methadone and buprenorphine, authorize new interventions such as supervised consumption sites and drug checking services, and advance novel drug research. LaSalle also pushes back on attempts to criminalize overdose through, for instance, drug-induced homicide, involuntary commitment, or fentanyl mandatory minimum laws.

LaSalle has been published in peer-reviewed journals and also regularly drafts reports for the Drug Policy Alliance. She has testified before numerous legislative and government bodies in the United States, including the United States Sentencing Commission, and is regularly invited as an expert to present at conferences and universities.

She received both her B.A. and J.D. from the University of California, Berkeley, where she served as development editor of the California Law Review. Prior to joining DPA, LaSalle worked at Morrison & Foerster LLP for three years on commercial litigation matters, while maintaining an active pro bono practice.
W06 - Innovative Harm Reduction Strategies for Stimulants

Krista McCormick
Manager, NPLEx/MethCheck & Subpoena Compliance
Appriss Health
Krista has been with Appriss for 11 years and has worked on NPLEx (National Precursor Log Exchange) since its inception. She has extensive experience with domestic meth production policy. She has been a part of every statewide NPLEx implementation and currently manages all 37 states focusing on driving program awareness. Krista serves as the subject matter expert for NPLEx and has presented to multiple law enforcement groups, pharmacists, and prosecutors. Krista has also testified in federal and state court all over the country.
W08 - Utilizing NPLEx to Proactively Attack Domestic Meth Production

Dawn Mertz
Executive Director
Arizona High Intensity Drug Trafficking Area (HIDTA)
Dawn Mertz has served as the Executive Director of the Arizona High Intensity Drug Trafficking Area (HIDTA) since June 2015. The HIDTA Program is a grant-funded initiative of the Office of National Drug Control Policy, which provides assistance to Federal, state, local, and tribal law enforcement agencies operating in areas determined to be critical drug trafficking regions of the United States.

Prior to her appointment as Executive Director of the Arizona HIDTA, Ms. Mertz spent 27 years as a criminal investigator for the Internal Revenue Service Criminal Investigation (IRS CI) Division. In February 2010, she was appointed Special Agent in Charge for the IRS CI Phoenix Field Office, where she was responsible for planning, directing, and evaluating activities of criminal investigation employees in the states of Arizona and New Mexico. During her time as Special Agent in Charge, Ms. Mertz served on the Executive Boards of the Arizona and New Mexico HIDTAs. She retired from the IRS in May 2015.

Ms. Mertz began her career as a Special Agent in Phoenix, working in Arizona for ten years followed by two years in Nevada. As a Special Agent for IRS CI, Ms. Mertz investigated a variety of financial crimes, which included money laundering, structuring, income tax evasion, and tax fraud. The focus of her money laundering cases included narcotics investigations and telemarketing fraud, as well as asset forfeiture.

As a Supervisory Special Agent in Fresno, California, Ms. Mertz supervised a group responsible for financial investigations in the Central Valley of California, including Fresno, Bakersfield, Modesto, and surrounding communities. She then worked at IRS headquarters in Washington D.C., as a Senior Analyst in the Planning and Strategy Section, before returning to Arizona in 2008 as the Assistant Special Agent in Charge for the IRS CI Phoenix Field Office.
Lunch and Panel Session - High Intensity Drug Trafficking Areas (HIDTA) Program Update

Justin Miller, PhD
Field Intelligence Manager, DEA Miami Field Division
Drug Enforcement Agency
Dr. Justin L. Miller currently serves as the Field Intelligence Manager for the Drug Enforcement Administration’s Miami Field Division. In this position, he leads the division’s Intelligence Program throughout the state of Florida, with responsibilities that include managing the collection, analysis, and dissemination of intelligence to identify and target for enforcement action significant drug trafficking organizations impacting the United States, and the production of strategic assessments on drug trafficking trends, emerging threats, and other national security concerns. He also serves as the division’s principal coordinator with the intelligence components of state, local, and other federal law enforcement agencies and the Intelligence Community. His previous leadership positions include supervising the DEA Intelligence unit in McAllen, Texas that covers the South Texas-Mexico border area, and directing the Financial Intelligence and Strategic Targeting units at DEA Headquarters. Dr. Miller also served at the El Paso Intelligence Center in El Paso, Texas, and in the DEA office in Cartagena, Colombia. Dr. Miller holds an M.A. and a Ph.D. from Baylor University.
W04 - Transnational Criminal Dynamics of the Rising Cocaine Threat

Siobhan Morse MHSA, CRC, CAI, MAC
Division Director of Clinical Services, CRC, CAI, MAC
Foundations Recovery Network
As Director of Clinical Services, Siobhan Morse is charged with spearheading the research, clinical operations management and new product development for Foundations Recovery Network, the Addiction Services Division of Universal Health Services, Inc. Ms. Morse regularly presents original research worldwide, has published multiple articles in peer reviewed scientific journals, and conducts education within the addiction services network. Ms. Morse joined Foundations Recovery Network in 2012 as Director of Research and Fidelity for Foundations Recovery Network, after having served for six years as Executive Director for the National Institute for Holistic Addiction Studies. Earlier in her career, she conducted clinical trials supporting new drug development for pharmaceutical manufacturers bringing new, life-saving medication to market. Ms. Morse holds a Master’s degree in Health Services Administration from Florida International University.  As an Adjunct Professor at Florida International University, Ms. Morse taught Program Planning and Evaluation for the College of Urban and Public Affairs. She holds her certifications as an ARISE Interventionist and as a Master Addiction Counselor. Ms. Morse also currently serves as voluntary adjunct faculty at Baylor College of Family Medicine.
W09 - The Changing Face of the Opioid Use Disorder Patient (1.5 CE)

Jules Netherland, PhD
Drug Policy Alliance
Julie “Jules” Netherland, PhD, is the Director of the Office of Academic Engagement for the Drug Policy Alliance. In that role, she advances drug policy reform by supporting scholars in doing advocacy, convening experts from a range of disciplines to inform the field, and strengthening DPA’s use of research and scholarship in developing and advancing its policy positions.
W06 - Innovative Harm Reduction Strategies for Stimulants

Kelly Page
Assistant Special Agent in Charge, Clandestine Laboratory Response Unit
North Carolina State Bureau of Investigation
Kelly Page is an Assistant Special Agent in Charge with the North Carolina State Bureau of Investigation. She has worked for the SBI for 17 ½ years. Kelly is currently the supervisor of the SBI’s Clandestine Laboratory Response Unit which is responsible for responding to and dismantling clandestine labs, including methamphetamine labs, and providing personal protective equipment to officers who enter hazardous environments. She has responded to over 600 labs, initially as a forensic chemist and later, as a site safety officer. Kelly also provides training on clandestine laboratories and fentanyl operations for various law enforcement groups, conferences, and associations.
W08 - Utilizing NPLEx to Proactively Attack Domestic Meth Production

Lia Pizzicato
Philadelphia Department of Public Health
Lia Pizzicato is the CDC/CSTE Applied Epidemiology Fellow at the Philadelphia Department of Public Health. Lia conducts epidemiology research and data analyses projects on substance use and mental health by developing and updating Philadelphia’s Opioid Misuse and Overdose Surveillance Dashboard, utilize Medicaid claims data to understand opioid prescribing trends in Philadelphia, and analyzing unintentional drug overdose fatality data to understand emerging trends in drug use. Prior to joining the Philadelphia Department of Public Health, Lia was a research assistant with the Connecticut Emerging Infections Program, where she conducted surveillance for E. coli, Salmonella, Campylobacter and other reportable enteric diseases; collected patient information from healthcare providers and local health departments & interviewed patient about their illnesses and exposures; maintained patient data in Maven Disease Surveillance Outbreak Management System and carried-out patient interviews during outbreak investigation of foodborne illnesses
PC05 - Leveraging Data to Monitor the Rise of Cocaine and Methamphetamine in Philadelphia

Howard Rosen
Assistant State Attorney, Deputy Chief for Special Prosecutions
Miami-Dade County State Attorney’s Office Eleventh Judicial Circuit of Florida
Howard Rosen is the Deputy Chief Assistant State Attorney for Special Prosecutions at the Miami-Dade County State Attorney’s Office, where he has supervisory responsibilities over all Public Corruption, Organized Crime, Narcotics, Gang, Insurance Fraud, Economic Crimes, and Cyber Crimes investigations and prosecutions.
W10 - The Investigation and Prosecution of Cocaine Trafficking Cases in Miami-Dade County Florida - An Overview of the Law, Effective Investigative Techniques, and Prosecutal Decisions, Methodologies and Results